| Jeffrey Martin, DO | |
|
225000 Hummingbird Rd Ste 100, Wausau, WI 54401-2950 | |
| (715) 359-6442 | |
| (715) 393-0390 |
| Full Name | Jeffrey Martin |
|---|---|
| Gender | Male |
| Speciality | Orthopedic Surgery |
| Experience | 15 Years |
| Location | 225000 Hummingbird Rd Ste 100, Wausau, Wisconsin |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639302623 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207X00000X | Orthopaedic Surgery | OT013120 (Pennsylvania) | Secondary |
| 207X00000X | Orthopaedic Surgery | 61724-21 (Wisconsin) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Aspirus Wausau Hospital | Wausau, WI | Hospital |
| Ascension St Marys Hospital | Rhinelander, WI | Hospital |
| Langlade Hospital | Antigo, WI | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Bone And Joint Clinic S.c. | 3678541919 | 44 |
News Archive
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
Caliper Life Sciences, Inc., today reported results for its third quarter ended September 30, 2010. Third quarter GAAP revenue decreased 8% to $29.7 million from $32.2 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 10% on a reported basis and 11% on an organic basis.
A Marshall University researcher has been awarded a one-year, $60,000 grant from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.
› Verified 1 days ago
| Entity Name | Bone & Joint Clinic S.c. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902850696 PECOS PAC ID: 3678541919 Enrollment ID: O20040923000705 |
News Archive
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
Caliper Life Sciences, Inc., today reported results for its third quarter ended September 30, 2010. Third quarter GAAP revenue decreased 8% to $29.7 million from $32.2 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 10% on a reported basis and 11% on an organic basis.
A Marshall University researcher has been awarded a one-year, $60,000 grant from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jeffrey Martin, DO 225000 Hummingbird Rd Ste 100, Wausau, WI 54401-2950 Ph: (715) 359-6442 | Jeffrey Martin, DO 225000 Hummingbird Rd Ste 100, Wausau, WI 54401-2950 Ph: (715) 359-6442 |
News Archive
MacuCLEAR, Inc., a clinical stage specialty pharmaceutical company focused on discovering and developing novel solutions for vascular disorders of the eye, announced today it is beginning Phase III studies for its lead compound, MC-1101, for early-stage (Dry) age-related macular degeneration (AMD), based on positive feedback during the company's end-of-Phase II meeting with the FDA.
Gentium S.p.A.today announced that the abstract titled, "Defibrotide prevents hepatic VOD and reduces significantly VOD-associated complications in children at high risk: final results of a prospective phase II/III multicenter study," was presented on Sunday, March 21, 2010, at the opening session of the European Blood and Marrow Transplantation 36th Annual Meeting in Vienna. The abstract received the esteemed Van Bekkum Award for the best abstract submitted to the physician's program. Dr. Selim Corbacioglu, Professor of Pediatrics, University of Regensburg (Germany) and Principal Investigator of the Pediatric Prevention trial, accepted the award and presented the final results of the study.
Another FDA-approved targeted cancer drug, sunitinib (SutentTM, Pfizer), may be associated with cardiac toxicity, report researchers at Children's Hospital Boston, Dana-Farber Cancer Institute (Boston), and Thomas Jefferson University (Philadelphia).
Caliper Life Sciences, Inc., today reported results for its third quarter ended September 30, 2010. Third quarter GAAP revenue decreased 8% to $29.7 million from $32.2 million in the same period in 2009 as a result of divestitures in 2010 and 2009. Revenue from on-going business increased 10% on a reported basis and 11% on an organic basis.
A Marshall University researcher has been awarded a one-year, $60,000 grant from the Pharmaceutical Research and Manufacturers of America (PhRMA) Foundation.
› Verified 1 days ago
Dr. Scott Remo Murch, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Stewart Ave, Wausau, WI 54401 Phone: 715-907-0900 Fax: 715-803-6977 | |
John James Verre, D.O. Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Stewart Ave, Wausau, WI 54401 Phone: 715-907-0900 Fax: 715-803-6977 | |
Eric Thiel, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 225000 Hummingbird Rd Ste 100, Wausau, WI 54401 Phone: 715-359-6442 Fax: 715-393-0390 | |
Wayne A Brearley, MD Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 3901 Stewart Ave, Wausau, WI 54401 Phone: 715-907-0900 Fax: 715-803-6977 | |
Dr. Roger Eugene Gregush, DO Orthopedic Surgery Medicare: Medicare Enrolled Practice Location: 225000 Hummingbird Rd Ste 100, Wausau, WI 54401 Phone: 800-445-6442 | |
William E Wessels Jr., MD Orthopedic Surgery Medicare: Not Enrolled in Medicare Practice Location: 5200 Hummingbird Rd, Suite 100, Wausau, WI 54401 Phone: 715-359-6442 Fax: 715-393-0391 | |
Daniel D Priebe, DO Orthopedic Surgery Medicare: Accepting Medicare Assignments Practice Location: 5200 Hummingbird Rd, Ste 100, Wausau, WI 54401 Phone: 715-359-6442 Fax: 715-393-0390 |